Scinai Immunotherapeutics (SCNI) Prepaid Assets (2018 - 2025)
Scinai Immunotherapeutics (SCNI) posted Prepaid Assets of $170000.0 for Q4 2025, down 27.97% sequentially from $236000.0 in Q2 2025, and down 20.19% YoY from $213000.0 in Q4 2024.
Scinai Immunotherapeutics (SCNI) Prepaid Assets (2018 - 2025) Analysis & Trends
Scinai Immunotherapeutics has reported Prepaid Assets for 6 years, with the latest figure at $170000.0 in Q4 2025.
- Quarterly Prepaid Assets fell 20.19% year-over-year to $170000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $170000.0 (down 20.19% YoY) and the FY2025 annual result came in at $170000.0, down 20.19% from the prior year.
- Prepaid Assets eased to $170000.0 in Q4 2025 per SCNI's latest filing, from $236000.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $437000.0 in Q4 2023 and troughed at $119000.0 in Q1 2023.
- A 5-year average of $224333.3 and a median of $213000.0 in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2024: Prepaid Assets soared 181.94% in 2023, then sank 51.26% in 2024.
- Over 5 years, Prepaid Assets stood at $227000.0 in 2021, then slumped by 31.72% to $155000.0 in 2022, then jumped by 181.94% to $437000.0 in 2023, then tumbled by 51.26% to $213000.0 in 2024, then decreased by 20.19% to $170000.0 in 2025.
- According to Business Quant data, Prepaid Assets over the past three periods registered $170000.0, $236000.0, and $213000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Scinai Immunotherapeutics | 11.72 Mn | -3.10 Bn | -1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 170,000.00 |
| Jun 30, 2025 | 236,000.00 |
| Dec 31, 2024 | 213,000.00 |
| Jun 30, 2024 | 324,000.00 |
| Dec 31, 2023 | 437,000.00 |
| Jun 30, 2023 | 138,000.00 |
| Mar 31, 2023 | 119,000.00 |
| Dec 31, 2022 | 155,000.00 |
| Dec 31, 2021 | 227,000.00 |
| Dec 31, 2018 | 156,000.00 |